Plateletpheresis yields: comparison of Baxter Amicus, Haemonetics MCS and Gambro Trima / 대한수혈학회지

BACKGROUND: The plateletpheresis yields are important to meet standard platelet transfusion doses and single donor platelets (SDPs) with fewer than 3.0x1011 can not be issued without approval from hospitals according to the regulations of Korea Red Cross blood center. This study evaluates platelet yields and plateletpheresis parameters of three different cell separators. METHODS: We used Amicus (Baxter, Deerfield, IL, U.S.A.), MCS+ (Haemonetics, Braintree, MA, U.S.A.) and Trima (Gambro BCT, Lakewood, U.S.A.) and collected a total of 2,303 units of leukocyte-reduced SDP(LRSDP). All separators were set up to target a platelet yield of 3.2x1011 and parameters were recorded for each collection. All units were divided into group 1(optimal platelet counts/unit) by platelet yields and separators. RESULTS: Three cell separators did not show any differences in the mean values of platelet yields. SDPs with 3.0x1011 or over were 87%, 91% and 87%, respectively. SDPs with more than optimal platelet counts per unit were 2%, 1% and 2%, respectively. SDPs collected by Trima had significantly higher values for pre-platelet count, total processing blood volume and used ACD volume. SDPs collected by MCS+ showed significant differences between groups in evaluated parameters including longer collecting time. CONCLUSION: All three separators provided satisfactory platelet yields with no significant differences among them. But platelet yields less than 3.0x1011 accounted for 9-13% of all collections. This study demonstrated that qualified management and thorough understanding of the plateletpheresis technology are necessary to increase productivity of SDPs with 3.0x1011 or over. It is also necessary to introduce new regulations and criteria for platelet yields, e.g. the yield-based pricing system.

Performance evaluation of AmicusTM and MCS + during plateletpheresis / 대한수혈학회지

BACKGROUND: Recently introduced plateletpheresis systems (AmicusTM software version 2.41 and MCS + LDP Rev. C) were evaluated for their performance. METHOD: Single-needle procedure was used for all donors, 127 with the AmicusTM and 85 with the MCS +. The targeted platelet yield was 3.2x1011. Components were evaluated for component yields, collection time, collection efficiency and incidence of donor reactions due to citrate. RESULTS: The collection time was significantly shorter with the AmicusTM (mean 57 min vs. 71 min, p< 0.05), and in 9 donors with a mean preapheresis platelet count of 325x103 /microliter the whole procedure could be completed within 40 minutes. However, the total processing time, including preprocessing and postprocessing time, between AmicusTM (78.0 min) and MCS + (74.3 min) was not statistically different. Mean platelet yield for AmicusTM and MCS + were 3.6x1011 and 3.4x1011, respectively. With 82.4% of SDPs collected with the MCS + having a platelet count of 3.0~3.9x1011, compared to 65.4% with the AmicusTM, the MCS + was more accurate in predicting the platelet yield of the final products. All components showed a residual WBC count of 5.0x106, and in 99.2% and 97.6% of components collected with the AmicusTM and MCS +, respectively, had a residual WBC count of less than 1.0x106. Mild donor reactions due to citrate tended to be more common on the MCS + (14.1%), which also used significantly more ACD (mean 342.5 mL vs. 268.0 mL, p< 0.05), than on the AmicusTM (5.5%). CONCLUSION: The plateletpheresis systems evaluated in this study allow the collection of leukoreduced SDPs of high quality within a reasonable time.

The Effects of Long-Term Plasmapheresis on the Iron Status of the Donors / 대한수혈학회지

BACKGROUND: We found that intensive and long-term plasmapheresis might be responsible for iron depletion of donors in our previous study. So we examined 88 multi-time and 44 first-time donors to investigate the effects of long-term plasmapheresis on the iron status of the body. METHODS: Eighty eight donors who had never donated whole blood or donated plasma only regularly over a period of 5 years were selected. They were divided into group 1, 2 and 3 by donation interval and group A, B and C by the number of plasmapheresis per year. Fifty eight of them had follow-up data after the donation. Whole blood was taken from the donors before plasmapheresis by the Fenwal Autopheresis-C system. Each sample was assayed for serum ferritin, iron, TIBC and transferrin saturation. RESLUTS: For serum ferritin, iron, TIBC and transferrin saturation, the mean values of multi-time donors were in the normal range but significantly lower than those of first-time donors. Twenty four (27.3%) multi-time donors had either less than 10 ng/mL of serum ferritin or less than 16% of transferrin saturation. Six donors had the lower values of both serum ferritin and transferrin saturation. Among 88 multi-time donors, there were significant differences between groups. Group 1 with the shortest donation interval had significantly lower ferritin value than the other groups. Group C with the highest donation frequency had significantly lower ferritin, TIBC and transferrin saturation values than the other groups. The results for the follow-up data of 58 donors were similar to those for the initial data. CONCLUSION: The donation intervals and the frequency of plasmapheresis influence body iron status of donors. So intensive and long-term plasmapheresis may result in iron depletion in donors. Consequently, a more sophisticated donor screening system to prevent iron depletion in intensive and long-term plasmapheresis donors should be established.

The Effects of Long-Term Plasmapheresis on Donors / 대한수혈학회지

BACKGROUND: Although many studies have demonstrated the well tolerance of intensive and long-term plasmapheresis in healthy donors, the effects on Korean donors have not been carefully investigated. Thirty donors were studied to investigate the effects of long-term plasmapheresis on Korean volunteer donors. METHODS: Thirty donors who had donated plasma regularly over a period of 3 years were selected. They were divided into group 1, 2 and 3 by the frequency of plasmapheresis per year and group A, B and C by the number of whole blood donations. Three of them had follow-up data at 7 days after. Whole blood was taken from the donors both before and after plasmapheresis by Fenwal Autopheresis-C system. Each sample was assayed for CBC, plasma total protein, albumin, IgG, IgA, IgM, ferritin and plasma hemoglobin. RESLUTS: For total protein, albumin, IgG, IgA and IgM, all the donors showed values in the normal range even with significant decreases after plasmapheresis. And there were no differences between groups. For ferritin, the mean values before and after plasmapheresis were 19.2 +/- 15.1 ng/mL and 17.8 +/- 15.2 ng/mL, respectively. In group 3 with highest frequency of plasmapheresis, the mean ferritin value was significantly lower than that of other groups as 7.3 +/- 5.0 (p<0.00.) Furthermore, the value was lower than 10 ng/mL which is the indicative value of iron depleted status. CONCLUSION: Long-term plasmapheresis donors had no significant changes in total protein, albumin, IgG, IgA and IgM. But they had mean ferritin values lower than the indicative value of iron depleted status. This implies that intensive and long-term plasmapheresis, might result iron depletion in donors. Consequently, a monitoring system to take care of regular plasmapheresis donation should be established.